What EGFR does in health and in cancer
Original title: Functions of the EGFR in health and disease.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a review of past science, not a new treatment you can get.
The short version
This paper reviews what scientists have learned about EGFR, a cell receptor that can help drive brain tumors.
What was studied. This is a review paper, not a new study. The authors go over past research on EGFR, much of it done in mice bred for this work.
What they found. EGFR helps the skin and brain grow and stay healthy. When it is too active or changed, it can drive cancer. The authors say this happens in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, a type of brain tumor, and in some lung, colon, liver, pancreas, and head and neck cancers.
What this means, and what it doesn't
What it could mean: Drugs that block EGFR are being studied for cancers like glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. This paper explains the science behind that idea. It may help you follow what your doctor means when EGFR comes up.
What it doesn't mean: This is not a new drug and not a new test result. It is a summary of past work, much of it done in mice or in the lab. Blocking EGFR is not a cure for brain tumors. Nothing here changes the care you can get today.
Source: PubMed, August 27, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.